The applicants must meet the following criteria: 

  • A technology or process development must focus on supporting the implementation of the Hydrogen Society Roadmap.
  •  Demonstrate a viable, feasible and sustainable business case.
  • Demonstrate a positive socio-economic impact.
  • Have a proof of concept (an idea that has been proven, tested and validated that requires support for further development or scale up) i.e. TRL 4 or more.

Applicants will be assessed against: 

Closing date

Eligible Enterprises

South African registered legal entity. A foreign entity will only be considered if it partners with a South African registered entity and the application is submitted by the South African entity.

Studies that fulfil the following non-financial criteria will be eligible to apply for a grant through the programme:

Target

  • High Education Institutions
  • Science Councils
  • Small Micro Medium Enterprises
  • Start-up companies

Technology Readiness Level

TRL 4 - 7

Usage of Fund 

Target

  • High Education Institutions
  • Science Councils
  • Small Micro Medium Enterprises
  • Start-up companies

Technology Readiness Level

TRL 3 - 8

Usage of Fund 

Target

  • High Education Institutions
  • Science Councils
  • Small Micro Medium Enterprises
  • Start-up companies

Technology Readiness Level

TRL 8

Usage of Fund 

Qualifying Criteria 

SMME, Co-Operative or Startup;

  • must operate in Gauteng and have its head office in Gauteng
  • be 100% South African owned
  • be trading for over a year
  • be registered with CIPC and
  • be compliant with SARS
  • have a valid South African identity document
  • and be 100% SA owned

Informal traders 

This invention is continuous flow reactor technology used to manufacture active pharmaceutical ingredients (APIs) for various drugs. 

These include AIDS (Emtricitabine, Lamivudine and Efavirenz), TB (Isoniazid), influenza (Tamiflu) and diabetes (Gliclazide, chlorpropamide, glipizide...